1. Chua WH, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113:2285-2291.
2. Chia A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012;119:347-354.
3. Tong L, et al. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology. 2009;116:572-579.
4. Chia A, et al. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology. 2016;123:391-399.
5. Dayan YB, et al. The changing prevalence of myopia in young adults: a 13-year series of population-based prevalence surveys. Investig. Opthalmology Vis. Sci. 2005;46:2760.
6. Smith TST, et al. Potential lost productivity resulting from the global burden of uncorrected refractive error. Bull. World Health Organ. 2009;87:431-437.
7. Cooke Bailey JN, et al. Advances in the genomics of common eye diseases. Hum. Mol. Genet. 2013;22:R59-R65.
8. He M, et al. Effect of Time Spent Outdoors at School on the Development of Myopia Among Children in China: A Randomized Clinical Trial. JAMA. 2015;314:1142.
9. Huang HM, Chang D-ST , Wu P-C. The Association between Near Work Activities and Myopia in Children—A Systematic Review and Meta-Analysis. PLoS One. 2015;10:e0140419.